tiprankstipranks
Trending News
More News >
Theravance Biopharma (TBPH)
NASDAQ:TBPH

Theravance Biopharma (TBPH) Revenue

Compare
343 Followers

Theravance Biopharma Revenue

Theravance Biopharma had a revenue of 19.99M in the quarter ending Sep 30, 2025, with -23.69%. This bring the company's revenue in the last twelve months to 80.33M, Decreased 4.04%. In the fiscal year ending Dec 31, 2024, Theravance Biopharma had annual revenue of 64.38M with 12.12% growth.
Revenue (ttm)
80.33M
Revenue Growth
27.12%
P/S Ratio
14.02
Revenue/Employee
$663,722
Employees
97
Market Cap
$902.48M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
64.38M6.96M+112.12%
Dec 31, 2023
57.42M6.08M+111.84%
Dec 31, 2022
51.35M-3.96M+92.83%
Dec 31, 2021
55.31M-16.55M+76.97%
Dec 31, 2020
71.86M-1.56M+97.88%
Dec 31, 2019
73.41M13.04M+121.61%
Dec 31, 2018
60.37M44.98M+392.37%
Dec 31, 2017
15.39M-33.26M+31.63%
Dec 31, 2016
48.65M